Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Age Factors [NCBI]


Gene


Gene Link Information
Gain
01




OMIM


OMIM Link Information
gain
01
MVP [NCBI] 0.00126235
MENOQ1 [NCBI] 0.00116078
VRNI [NCBI] 0.00105928
KLK3 [NCBI] 0.00102639
MCKD1 [NCBI] 0.000764109
deafness, progressive high-tone neural [NCBI] 0.000740757
iris pattern [NCBI] 0.00068372
hyperpigmentation of eyelids [NCBI] 0.00068372
body mass index quantitative trait locus on chromosome 20, in children [NCBI] 0.00068372
mammographic density [NCBI] 0.00068372
myopathy, distal, with onset in infancy [NCBI] 0.00068372
MENAQ1 [NCBI] 0.00068372
amyotrophic lateral sclerosis, juvenile, with dementia [NCBI] 0.00068372
body mass index quantitative trait locus on chromosome 16, in children [NCBI] 0.00068372
PCD [NCBI] 0.000625914
MDD [NCBI] 0.000616093
acrodysostosis [NCBI] 0.000594154
nephrolithiasis, calcium oxalate [NCBI] 0.000594154
CGF [NCBI] 0.000540104
CMM [NCBI] 0.000529569
MAFD2 [NCBI] 0.00052687
APOE [NCBI] 0.000457185
primary lateral sclerosis, adult [NCBI] 0.000423934
osteoarthropathy of fingers, familial [NCBI] 0.000423934
nail dysplasia [NCBI] 0.000423934
CACD [NCBI] 0.000423934
diabetes mellitus, noninsulin-dependent, 4 [NCBI] 0.000423934
asparagus, specific smell hypersensitivity [NCBI] 0.000423934
nevus flammeus of nape of neck [NCBI] 0.000423934
aneurysm, intracranial berry, 3 [NCBI] 0.000423934
VMD1 [NCBI] 0.000423934
sjogren syndrome [NCBI] 0.000419191
AD [NCBI] 0.000399593
DYT2 [NCBI] 0.000388023
r binder deficiency with lactoferrin deficiency [NCBI] 0.00032926
transient erythroblastopenia of childhood [NCBI] 0.00032926
OPA2 [NCBI] 0.00032926
ATFB1 [NCBI] 0.00032926
cataract, autosomal recessive, early-onset, pulverulent [NCBI] 0.00032926
vitreoretinal degeneration, snowflake type [NCBI] 0.00032926
STUT1 [NCBI] 0.00032926
wilms tumor 4 [NCBI] 0.00032926
astigmatism [NCBI] 0.00032926
autoimmune thyroid disease, susceptibility to, 2 [NCBI] 0.00032926
cataract, age-related cortical [NCBI] 0.00032926
HD [NCBI] 0.000317625
metachromatic leukodystrophy [NCBI] 0.00031217
PAND1 [NCBI] 0.000311785
glaucoma-related pigment dispersion syndrome [NCBI] 0.000311785
IDDM [NCBI] 0.000307076
panencephalitis, subacute sclerosing [NCBI] 0.000283352
cholesterol level quantitative trait locus 1 [NCBI] 0.000269684
spondyloenchondrodysplasia [NCBI] 0.000269684
MPD2 [NCBI] 0.000269684
cholestasis-lymphedema syndrome [NCBI] 0.000269684
SCAR2 [NCBI] 0.000269684
PPPP [NCBI] 0.000269684
carnosinemia [NCBI] 0.000269684
eosinophilia, familial [NCBI] 0.000269684
laryngeal abductor paralysis [NCBI] 0.000269684
PPR [NCBI] 0.000256199
abdominal obesity-metabolic syndrome [NCBI] 0.000253636
IGAN1 [NCBI] 0.000253636
aneurysm, intracranial berry, 1 [NCBI] 0.000237159
spinal muscular atrophy, childhood, proximal, autosomal dominant [NCBI] 0.000226777
FECD2 [NCBI] 0.000226777
torus palatinus and torus mandibularis [NCBI] 0.000226777
GLC1C [NCBI] 0.000226777
BZX [NCBI] 0.000226777
splenic hypoplasia [NCBI] 0.000226777
diabetes mellitus, insulin-dependent, x-linked, susceptibility to [NCBI] 0.000226777
plasmodium falciparum blood infection level [NCBI] 0.000226777
ETM2 [NCBI] 0.000226777
glomerulopathy with fibronectin deposits [NCBI] 0.000226777
parkinsonism with alveolar hypoventilation and mental depression [NCBI] 0.000226777
letterer-siwe disease [NCBI] 0.000226777
SHBG [NCBI] 0.000226357
SRS [NCBI] 0.00022479
VUR1 [NCBI] 0.000221869
breast cancer [NCBI] 0.000205586
CHAT [NCBI] 0.000202063
trichoepithelioma, multiple familial [NCBI] 0.000193689
jejunal atresia [NCBI] 0.000193689
precocious puberty [NCBI] 0.000193689
vestibulopathy, familial [NCBI] 0.000193689
SCZD10 [NCBI] 0.000193689
actinic prurigo [NCBI] 0.000193689
STHAG4 [NCBI] 0.000193689
EOCA [NCBI] 0.000193689
HMN7A [NCBI] 0.000193689
CLN4A [NCBI] 0.000193689
kyphomelic dysplasia [NCBI] 0.000193689
visceral myopathy, familial, with external ophthalmoplegia [NCBI] 0.000193689
BDNF [NCBI] 0.000189393
ETM1 [NCBI] 0.000187915
TNF [NCBI] 0.000170908
maxillonasal dysplasia, binder type [NCBI] 0.000167088
ECA1 [NCBI] 0.000167088
hodgkin disease, x-linked pseudoautosomal [NCBI] 0.000167088
beta-aminoisobutyric acid, urinary excretion of [NCBI] 0.000167088
HMN1 [NCBI] 0.000167088
cluster headache, familial [NCBI] 0.000167088
schistosoma mansoni infection, susceptibility/resistance to [NCBI] 0.000167088
IS1 [NCBI] 0.000164712
CRC [NCBI] 0.000163599
MEN2A [NCBI] 0.000159578
migraine with or without aura, susceptibility to, 1 [NCBI] 0.000159513
glycogen storage disease ii [NCBI] 0.000149875
restless legs syndrome, susceptibility to, 1 [NCBI] 0.000149307
earlobe crease [NCBI] 0.000149263
strabismus, susceptibility to [NCBI] 0.000145099
CTS1 [NCBI] 0.000145099
skin creases, multiple benign ring-shaped, of limbs [NCBI] 0.000145099
DFN2 [NCBI] 0.000145099
RCD1 [NCBI] 0.000145099
neutropenia, chronic familial [NCBI] 0.000145099
prostate cancer, hereditary, 8 [NCBI] 0.000145099
apnea, obstructive sleep [NCBI] 0.000136003
GFAP [NCBI] 0.000130594
hypertension with brachydactyly [NCBI] 0.000126557
CDB2 [NCBI] 0.000126557
IGES [NCBI] 0.000126557
NF2 [NCBI] 0.000124069
palatopharyngeal incompetence [NCBI] 0.000122193
RA [NCBI] 0.000121177
centralopathic epilepsy [NCBI] 0.000110693
spatial visualization, aptitude for [NCBI] 0.000110693
HPCX [NCBI] 0.000110693
musical perfect pitch [NCBI] 0.000109014
EGF [NCBI] 0.000106977
pernicious anemia [NCBI] 0.000106
MODY [NCBI] 9.97903e-05
MAFD6 [NCBI] 9.91056e-05
aortic valve disease [NCBI] 9.90857e-05
WDM [NCBI] 9.69662e-05
OTSC1 [NCBI] 9.69662e-05
alzheimer disease 6 [NCBI] 9.69662e-05
amyloidosis vi [NCBI] 9.58626e-05
MG [NCBI] 9.58097e-05
BWS [NCBI] 9.33527e-05
myxoma, intracardiac [NCBI] 8.92718e-05
nephrotic syndrome, early-onset, with diffuse mesangial sclerosis [NCBI] 8.92718e-05
resting heart rate [NCBI] 8.92718e-05
MTC [NCBI] 8.54233e-05
ETL2 [NCBI] 8.49878e-05
telomere length, mean leukocyte [NCBI] 8.49878e-05
HP [NCBI] 8.37021e-05
XFS [NCBI] 8.04836e-05
FA [NCBI] 7.96976e-05
FSHMD1A [NCBI] 7.94518e-05
NGFB [NCBI] 7.79877e-05
FCDT [NCBI] 7.79645e-05
cd4/cd8 t-cell ratio [NCBI] 7.79645e-05
carney triad [NCBI] 7.79645e-05
cystinosis, late-onset juvenile or adolescent nephropathic type [NCBI] 7.79645e-05
POAG [NCBI] 7.7038e-05
MODY1 [NCBI] 7.6008e-05
ARMD1 [NCBI] 7.55775e-05
ACHE [NCBI] 7.49566e-05
FEB1 [NCBI] 7.4465e-05
OD [NCBI] 7.4465e-05
mesothelioma, malignant [NCBI] 7.4465e-05
IDDM4 [NCBI] 7.4465e-05
hemoglobin, high oxygen saturation of [NCBI] 7.18423e-05
mycosis fungoides [NCBI] 7.18423e-05
folate level in erythrocytes [NCBI] 7.18423e-05
motion sickness [NCBI] 7.18423e-05
angiolipomatosis, familial [NCBI] 7.18423e-05
BOE [NCBI] 7.18423e-05
necrotizing encephalomyelopathy, subacute, of leigh, adult [NCBI] 7.18423e-05
normokalemic periodic paralysis [NCBI] 7.18423e-05
CMH2 [NCBI] 7.18423e-05
tibia vara [NCBI] 7.18423e-05
low density lipoprotein, variation in molecular weight of [NCBI] 7.18423e-05
dicarboxylicamino aciduria [NCBI] 7.18423e-05
porokeratosis plantaris, palmaris, et disseminata [NCBI] 7.18423e-05
phenformin 4-hydroxylation [NCBI] 7.18423e-05
PGP1 [NCBI] 7.18423e-05
muscular atrophy, malignant neurogenic [NCBI] 7.18423e-05
ackerman syndrome [NCBI] 7.18423e-05
leishmaniasis, tegumentary [NCBI] 7.18423e-05
DHFR [NCBI] 6.77176e-05
OMP [NCBI] 6.35646e-05
SPMM [NCBI] 6.26047e-05
hypotrichosis simplex of scalp [NCBI] 6.26047e-05
legg-calve-perthes disease [NCBI] 6.26047e-05
BL [NCBI] 5.78805e-05
TRS [NCBI] 5.69407e-05
vitiligo [NCBI] 5.69407e-05
CCAL2 [NCBI] 5.31323e-05
lactase persistence [NCBI] 5.20602e-05
TSD [NCBI] 5.18931e-05
klippel-trenaunay-weber syndrome [NCBI] 5.08241e-05
aortic aneurysm, abdominal [NCBI] 5.06833e-05
TH [NCBI] 5.00135e-05
PSORS1 [NCBI] 4.99874e-05
hodgkin lymphoma [NCBI] 4.83783e-05
CLN1 [NCBI] 4.83783e-05
GBD1 [NCBI] 4.79417e-05
HCHWAD [NCBI] 4.79417e-05
polycystic kidneys [NCBI] 4.72413e-05
GCKR [NCBI] 4.70091e-05
EKD1 [NCBI] 4.68077e-05
VEGF [NCBI] 4.67564e-05
PTH [NCBI] 4.62247e-05
CRMO [NCBI] 4.6204e-05
AMH [NCBI] 4.61677e-05
DGS [NCBI] 4.60045e-05
PGR [NCBI] 4.57018e-05
wilson disease [NCBI] 4.48298e-05
ARMD3 [NCBI] 4.46313e-05
torticollis [NCBI] 4.46313e-05
acrogeria, gottron type [NCBI] 4.46313e-05
osteogenesis imperfecta with opalescent teeth [NCBI] 4.46313e-05
pulmonary hypertension, primary, autosomal recessive [NCBI] 4.46313e-05
hyperostosis frontalis interna [NCBI] 4.46313e-05
geographic tongue and fissured tongue [NCBI] 4.46313e-05
coarctation of aorta [NCBI] 4.46313e-05
muscular dystrophy, scapulohumeral [NCBI] 4.46313e-05
paralysis agitans, juvenile, of hunt [NCBI] 4.46313e-05
magnesium, elevated red cell [NCBI] 4.46313e-05
chorea, benign familial [NCBI] 4.46313e-05
IRID1 [NCBI] 4.42669e-05
PFHB1A [NCBI] 4.42669e-05
IRID2 [NCBI] 4.42669e-05
HSAN3 [NCBI] 4.41606e-05
NEM3 [NCBI] 4.41492e-05
cayler cardiofacial syndrome [NCBI] 4.30898e-05
FRDA [NCBI] 4.2895e-05
MTTR [NCBI] 4.25028e-05
HGF [NCBI] 4.16598e-05
SLC18A3 [NCBI] 4.11531e-05
CCK [NCBI] 4.105e-05
amyloidosis, primary cutaneous [NCBI] 4.09989e-05
osteoporosis, juvenile [NCBI] 4.09989e-05
CLN5 [NCBI] 4.09989e-05
SPP1 [NCBI] 3.94245e-05
CF [NCBI] 3.91413e-05
HFE [NCBI] 3.81272e-05
CDGG1 [NCBI] 3.80663e-05
AFP [NCBI] 3.77932e-05
autism [NCBI] 3.6982e-05
alzheimer disease 3 [NCBI] 3.69408e-05
ARMD4 [NCBI] 3.54148e-05
gm1-gangliosidosis, type iii [NCBI] 3.54148e-05
hypophosphatasia, infantile [NCBI] 3.53545e-05
NRCLP1 [NCBI] 3.53545e-05
STL1 [NCBI] 3.53545e-05
PRL [NCBI] 3.52842e-05
sickle cell anemia [NCBI] 3.51643e-05
DRPLA [NCBI] 3.50176e-05
spastic ataxia [NCBI] 3.47111e-05
arcus corneae [NCBI] 3.47111e-05
mydriatic response to pharmacologic agents [NCBI] 3.47111e-05
macular dystrophy, concentric annular [NCBI] 3.47111e-05
fundus dystrophy, pseudoinflammatory, recessive form [NCBI] 3.47111e-05
MODY8 [NCBI] 3.47111e-05
mass syndrome [NCBI] 3.47111e-05
bernard-soulier syndrome, benign autosomal dominant [NCBI] 3.47111e-05
retinitis pigmentosa, late-adult onset [NCBI] 3.47111e-05
NEK1 [NCBI] 3.47111e-05
thymoma, familial [NCBI] 3.47111e-05
brugada syndrome 2 [NCBI] 3.47111e-05
glutamate monosodium sensitivity [NCBI] 3.47111e-05
muscular dystrophy, hemizygous lethal type [NCBI] 3.47111e-05
PD [NCBI] 3.42699e-05
GCK [NCBI] 3.37384e-05
ADLTE [NCBI] 3.30026e-05
BHC [NCBI] 3.30026e-05
hypophosphatasia, adult type [NCBI] 3.30026e-05
SCA1 [NCBI] 3.28477e-05
FMF [NCBI] 3.2278e-05
VDR [NCBI] 3.20942e-05
NF1 [NCBI] 3.13264e-05
CD [NCBI] 3.12532e-05
SPG3A [NCBI] 3.10217e-05
SMA1 [NCBI] 3.06216e-05
NPC1 [NCBI] 2.89056e-05
temporal arteritis [NCBI] 2.86342e-05
methane production [NCBI] 2.84663e-05
larynx, congenital partial atresia of [NCBI] 2.84663e-05
australia antigen [NCBI] 2.84663e-05
OPTA1 [NCBI] 2.84663e-05
respiratory underresponsiveness to hypoxia and hypercapnia [NCBI] 2.84663e-05
buruli ulcer, susceptibility to [NCBI] 2.84663e-05
ascaris lumbricoides infection, susceptibility to [NCBI] 2.84663e-05
TBDN [NCBI] 2.84663e-05
leigh syndrome, x-linked [NCBI] 2.84663e-05
varicose veins [NCBI] 2.84663e-05
sarcoidosis, early-onset [NCBI] 2.84663e-05
roussy-levy hereditary areflexic dystasia [NCBI] 2.84663e-05
paroxysmal tonic upgaze, benign childhood, with ataxia [NCBI] 2.84663e-05
bilirubin, elevated concentrations of, in serum [NCBI] 2.84663e-05
hyperlysinemia [NCBI] 2.84663e-05
MCDR1 [NCBI] 2.74505e-05
SMA3 [NCBI] 2.72379e-05
SOX12 [NCBI] 2.68981e-05
FOXN4 [NCBI] 2.68981e-05
HSCR1 [NCBI] 2.6636e-05
LFS1 [NCBI] 2.60821e-05
PRNP [NCBI] 2.53395e-05
GLC1A [NCBI] 2.49741e-05
niemann-pick disease, type c2 [NCBI] 2.3967e-05
JAE [NCBI] 2.3967e-05
n-acetylglutamate synthase deficiency [NCBI] 2.3967e-05
hypotension, orthostatic [NCBI] 2.3967e-05
lichen planus, familial [NCBI] 2.3967e-05
epidermolysis bullosa of hands and feet [NCBI] 2.3967e-05
cardiac conduction defect [NCBI] 2.3967e-05
metaphyseal chondrodysplasia, jansen type [NCBI] 2.3967e-05
white sponge nevus of cannon [NCBI] 2.3967e-05
cystinosis, adult nonnephropathic [NCBI] 2.3967e-05
novelty seeking personality trait [NCBI] 2.3967e-05
CVG/MR [NCBI] 2.3967e-05
melanoma-pancreatic cancer syndrome [NCBI] 2.3967e-05
EIG [NCBI] 2.39403e-05
PROS1 [NCBI] 2.38836e-05
LAM [NCBI] 2.38111e-05
MEN1 [NCBI] 2.35664e-05
LKS [NCBI] 2.28913e-05
HEMB [NCBI] 2.25122e-05
CPI [NCBI] 2.18458e-05
RB1 [NCBI] 2.14966e-05
HDL2 [NCBI] 2.04959e-05
ectopia lentis, isolated [NCBI] 2.04959e-05
glaucoma, normal tension, susceptibility to [NCBI] 2.04959e-05
HCA2 [NCBI] 2.04959e-05
nasopharyngeal carcinoma [NCBI] 2.04959e-05
corneal dystrophy, epithelial basement membrane [NCBI] 2.04959e-05
DFNA1 [NCBI] 2.04959e-05
UL [NCBI] 2.04959e-05
creatine phosphokinase, elevated serum [NCBI] 2.04959e-05
DFNA20 [NCBI] 2.04959e-05
thrombocytopenic purpura, autoimmune [NCBI] 2.0459e-05
ITGA2 [NCBI] 2.04195e-05
glycogen storage disease i [NCBI] 2.01181e-05
GTS [NCBI] 1.96997e-05
dubowitz syndrome [NCBI] 1.96566e-05
menkes disease [NCBI] 1.92934e-05
MAFD1 [NCBI] 1.90811e-05
ALB [NCBI] 1.89881e-05
dad1-related gene [NCBI] 1.87155e-05
FETUB [NCBI] 1.87155e-05
UHMK1 [NCBI] 1.87155e-05
BHLHB4 [NCBI] 1.87155e-05
BCL2L2 [NCBI] 1.87155e-05
ETNK1 [NCBI] 1.87155e-05
GLDN [NCBI] 1.87155e-05
SLOS [NCBI] 1.82264e-05
LIP [NCBI] 1.8154e-05
alcohol dependence [NCBI] 1.8154e-05
osteoporosis [NCBI] 1.8154e-05
ADRB1 [NCBI] 1.814e-05
PJS [NCBI] 1.79106e-05
GRIA1 [NCBI] 1.78579e-05
ectodermal dysplasia, anhidrotic [NCBI] 1.77041e-05
body mass index [NCBI] 1.77041e-05
DSAP1 [NCBI] 1.77041e-05
CSNB1B [NCBI] 1.77041e-05
acromesomelic dysplasia, hunter-thompson type [NCBI] 1.77041e-05
aplastic anemia [NCBI] 1.77041e-05
floating-harbor syndrome [NCBI] 1.77041e-05
pneumothorax, primary spontaneous [NCBI] 1.77041e-05
fragile x mental retardation syndrome [NCBI] 1.72838e-05
TTR [NCBI] 1.71508e-05
PDB [NCBI] 1.70104e-05
CTGF [NCBI] 1.70097e-05
CFTR [NCBI] 1.68737e-05
RELN [NCBI] 1.68622e-05
CMT1B [NCBI] 1.67849e-05
neuroblastoma [NCBI] 1.67849e-05
GDNF [NCBI] 1.66816e-05
GHRH [NCBI] 1.65214e-05
hypertrophic neuropathy of dejerine-sottas [NCBI] 1.60405e-05
pheochromocytoma [NCBI] 1.59366e-05
SMA2 [NCBI] 1.59366e-05
lung cancer [NCBI] 1.59366e-05
HS1BP3 [NCBI] 1.56676e-05
PACSIN2 [NCBI] 1.56676e-05
AGTPBP1 [NCBI] 1.56676e-05
C1ORF36 [NCBI] 1.56676e-05
SMC1B [NCBI] 1.56676e-05
MLL2 [NCBI] 1.56676e-05
SEMA5B [NCBI] 1.56676e-05
PPARA [NCBI] 1.55529e-05
ADHD [NCBI] 1.54661e-05
CHED2 [NCBI] 1.53951e-05
FANCB [NCBI] 1.53951e-05
spinal muscular atrophy, proximal, adult, autosomal dominant [NCBI] 1.53951e-05
ear wax, wet/dry [NCBI] 1.53951e-05
ehlers-danlos syndrome, type iii [NCBI] 1.53951e-05
deafness, aminoglycoside-induced [NCBI] 1.53951e-05
psoriatic arthritis, susceptibility to [NCBI] 1.53951e-05
IDD [NCBI] 1.53951e-05
IBMPFD [NCBI] 1.53951e-05
AMDM [NCBI] 1.53951e-05
hypertriglyceridemia, familial [NCBI] 1.53951e-05
obesity [NCBI] 1.53239e-05
OPMD [NCBI] 1.5049e-05
SELP [NCBI] 1.47373e-05
SLC18A2 [NCBI] 1.42885e-05
AIS [NCBI] 1.42483e-05
ICA1 [NCBI] 1.3711e-05
PTPRS [NCBI] 1.3711e-05
FEZF2 [NCBI] 1.3711e-05
FAIM2 [NCBI] 1.3711e-05
GPD1L [NCBI] 1.3711e-05
PRMT3 [NCBI] 1.3711e-05
CFHR3 [NCBI] 1.3711e-05
CPEB1 [NCBI] 1.3711e-05
PRSS8 [NCBI] 1.3711e-05
UBC [NCBI] 1.3711e-05
POU6F2 [NCBI] 1.3711e-05
OPTA2 [NCBI] 1.34471e-05
PLSJ [NCBI] 1.34471e-05
tobacco addiction, susceptibility to [NCBI] 1.34471e-05
caffey disease [NCBI] 1.34471e-05
INAD1 [NCBI] 1.34471e-05
hyperlipidemia, combined, 1 [NCBI] 1.34471e-05
macular dystrophy, vitelliform, adult-onset [NCBI] 1.34471e-05
polydactyly, postaxial, type a1 [NCBI] 1.34471e-05
IS [NCBI] 1.34471e-05
HES [NCBI] 1.34471e-05
mitochondrial myopathy [NCBI] 1.34471e-05
leiomyomatosis and renal cell cancer, hereditary [NCBI] 1.30819e-05
testicular tumors [NCBI] 1.30819e-05
RBP3 [NCBI] 1.30085e-05
ACP5 [NCBI] 1.29403e-05
CD [NCBI] 1.29263e-05
EGFR [NCBI] 1.29144e-05
GPD1 [NCBI] 1.22728e-05
EDG2 [NCBI] 1.22728e-05
CHI3L1 [NCBI] 1.22728e-05
TSTA3 [NCBI] 1.22728e-05
SIM1 [NCBI] 1.22728e-05
ACLY [NCBI] 1.22728e-05
EFEMP1 [NCBI] 1.22728e-05
CPB1 [NCBI] 1.22728e-05
DMTF1 [NCBI] 1.22728e-05
ELA1 [NCBI] 1.22728e-05
MEF2D [NCBI] 1.22728e-05
PG [NCBI] 1.22657e-05
COMP [NCBI] 1.22597e-05
homocysteinemia [NCBI] 1.22381e-05
NPPA [NCBI] 1.21902e-05
PTK2 [NCBI] 1.20757e-05
FRAP1 [NCBI] 1.20705e-05
HBB [NCBI] 1.20006e-05
hla-d histocompatibility type [NCBI] 1.19523e-05
AVP [NCBI] 1.18893e-05
SCN3 [NCBI] 1.17794e-05
alzheimer disease 4 [NCBI] 1.17794e-05
gm1-gangliosidosis, type ii [NCBI] 1.17794e-05
stuve-wiedemann syndrome [NCBI] 1.17794e-05
WZS [NCBI] 1.17794e-05
muenke syndrome [NCBI] 1.17794e-05
MUC1 [NCBI] 1.16415e-05
protein c deficiency, congenital thrombotic disease due to [NCBI] 1.13768e-05
RBP1 [NCBI] 1.13689e-05
IRS2 [NCBI] 1.12399e-05
MJD [NCBI] 1.11572e-05
GFRA2 [NCBI] 1.11399e-05
LHX9 [NCBI] 1.11399e-05
HMCN1 [NCBI] 1.11399e-05
GCSH [NCBI] 1.11399e-05
SRG1 [NCBI] 1.11399e-05
SLC16A7 [NCBI] 1.11399e-05
ARNT2 [NCBI] 1.11399e-05
GJB4 [NCBI] 1.11399e-05
POU4F1 [NCBI] 1.11399e-05
ST8SIA1 [NCBI] 1.11399e-05
SOX5 [NCBI] 1.11399e-05
OLIG1 [NCBI] 1.11399e-05
KIF11 [NCBI] 1.11399e-05
NIPA1 [NCBI] 1.11399e-05
PFTK1 [NCBI] 1.11399e-05
BIK [NCBI] 1.11399e-05
GRIK2 [NCBI] 1.11399e-05
PSEN1 [NCBI] 1.10299e-05
fructose intolerance, hereditary [NCBI] 1.0927e-05
SLC40A1 [NCBI] 1.0927e-05
gastric cancer [NCBI] 1.06905e-05
FCHL [NCBI] 1.06905e-05
PENK [NCBI] 1.06238e-05
SMAX1 [NCBI] 1.05956e-05
ACH [NCBI] 1.04735e-05
COMT [NCBI] 1.03504e-05
MODY3 [NCBI] 1.03356e-05
ATS [NCBI] 1.03356e-05
SPG6 [NCBI] 1.03356e-05
galactokinase deficiency [NCBI] 1.03356e-05
LGMD1A [NCBI] 1.03356e-05
cirrhosis, familial [NCBI] 1.03356e-05
IFD [NCBI] 1.03356e-05
PHA1 [NCBI] 1.03356e-05
scheie syndrome [NCBI] 1.03356e-05
gracile syndrome [NCBI] 1.03356e-05
CMT2A2 [NCBI] 1.03356e-05
CNGA2 [NCBI] 1.02088e-05
PMX1 [NCBI] 1.02088e-05
PPARGC1B [NCBI] 1.02088e-05
FBLN5 [NCBI] 1.02088e-05
MIA [NCBI] 1.02088e-05
HOXB4 [NCBI] 1.02088e-05
PPP1R3A [NCBI] 1.02088e-05
BRCA1 [NCBI] 9.95637e-06
MAS [NCBI] 9.82561e-06
PMD [NCBI] 9.78058e-06
APOA1 [NCBI] 9.75846e-06
STAT3 [NCBI] 9.60143e-06
PWS [NCBI] 9.4905e-06
WAS [NCBI] 9.44095e-06
SLC11A2 [NCBI] 9.4337e-06
PDE10A [NCBI] 9.42101e-06
TST [NCBI] 9.42101e-06
VTN [NCBI] 9.42101e-06
CHIT1 [NCBI] 9.42101e-06
CHRNG [NCBI] 9.42101e-06
tl antigen [NCBI] 9.42101e-06
INHBB [NCBI] 9.42101e-06
complement component 8 deficiency, type ii [NCBI] 9.42101e-06
POU3F1 [NCBI] 9.42101e-06
GNRH1 [NCBI] 9.38951e-06
leber optic atrophy [NCBI] 9.30117e-06
SNCA [NCBI] 9.27559e-06
ASPA [NCBI] 9.27188e-06
LTA [NCBI] 9.27188e-06
HRG [NCBI] 9.12024e-06
HFM [NCBI] 9.08665e-06
DFNA6 [NCBI] 9.0747e-06
SFD [NCBI] 9.0747e-06
hyperlipoproteinemia, type ii [NCBI] 9.0747e-06
ALUNC [NCBI] 9.0747e-06
sarcoidosis [NCBI] 9.0747e-06
CMT4A [NCBI] 9.0747e-06
SMDP1 [NCBI] 9.0747e-06
methylmalonic aciduria and homocystinuria, cblc type [NCBI] 9.0747e-06
IHPS1 [NCBI] 9.0747e-06
acheiropody [NCBI] 9.0747e-06
leiomyoma, hereditary multiple, of skin [NCBI] 9.0747e-06
renal cysts and diabetes syndrome [NCBI] 9.0747e-06
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism [NCBI] 9.0747e-06
XPF [NCBI] 9.0747e-06
danubian endemic familial nephropathy [NCBI] 9.04251e-06
prostate cancer [NCBI] 8.99121e-06
HBFQTL2 [NCBI] 8.79636e-06
PDYN [NCBI] 8.79149e-06
GAMT [NCBI] 8.79149e-06
FGF19 [NCBI] 8.74044e-06
ABCG8 [NCBI] 8.74044e-06
CCKBR [NCBI] 8.74044e-06
EDNRA [NCBI] 8.74044e-06
CFHR1 [NCBI] 8.74044e-06
SEMA5A [NCBI] 8.74044e-06
HDAC9 [NCBI] 8.74044e-06
NOTCH4 [NCBI] 8.74044e-06
GSTZ1 [NCBI] 8.74044e-06
HBQ1 [NCBI] 8.74044e-06
DAB1 [NCBI] 8.74044e-06
BRCA2 [NCBI] 8.71017e-06
OCA2 [NCBI] 8.67655e-06
PCTT [NCBI] 8.67655e-06
TYMS [NCBI] 8.65903e-06
WRN [NCBI] 8.63421e-06
MYH11 [NCBI] 8.56266e-06
LCAT [NCBI] 8.29905e-06
PMCH [NCBI] 8.29905e-06
ACPP [NCBI] 8.25325e-06
NRP2 [NCBI] 8.14308e-06
APOA5 [NCBI] 8.14308e-06
SLC5A6 [NCBI] 8.14308e-06
NES [NCBI] 8.14308e-06
CTSG [NCBI] 8.14308e-06
EYA2 [NCBI] 8.14308e-06
AMT [NCBI] 8.14308e-06
FSTL1 [NCBI] 8.14308e-06
PABPN1 [NCBI] 8.14308e-06
SLC30A3 [NCBI] 8.14308e-06
HGPS [NCBI] 8.09588e-06
SVAS [NCBI] 8.09588e-06
gaucher disease, type i [NCBI] 8.09588e-06
CMTX1 [NCBI] 8.0776e-06
CP [NCBI] 8.02433e-06
alzheimer disease 2 [NCBI] 7.96619e-06
wolff-parkinson-white syndrome [NCBI] 7.96619e-06
crouzon syndrome [NCBI] 7.96619e-06
CMT2A1 [NCBI] 7.96619e-06
WS2A [NCBI] 7.96619e-06
autoimmune disease [NCBI] 7.96619e-06
cutis laxa, autosomal recessive, type i [NCBI] 7.96619e-06
ALS2 [NCBI] 7.96619e-06
amyloidosis v [NCBI] 7.96619e-06
septooptic dysplasia [NCBI] 7.96619e-06
LRP1 [NCBI] 7.82604e-06
NS1 [NCBI] 7.71436e-06
LBP [NCBI] 7.7046e-06
F3 [NCBI] 7.62917e-06
RTN1 [NCBI] 7.6122e-06
ZMPSTE24 [NCBI] 7.6122e-06
TREM2 [NCBI] 7.6122e-06
HOXA1 [NCBI] 7.6122e-06
PAX7 [NCBI] 7.6122e-06
MYT1 [NCBI] 7.6122e-06
SGCB [NCBI] 7.6122e-06
HK2 [NCBI] 7.6122e-06
NID [NCBI] 7.6122e-06
PON1 [NCBI] 7.46366e-06
PF4 [NCBI] 7.42457e-06
AT [NCBI] 7.37046e-06
BGLAP [NCBI] 7.36733e-06
SLC6A4 [NCBI] 7.27336e-06
APCS [NCBI] 7.14201e-06
KRT17 [NCBI] 7.13565e-06
GNPAT [NCBI] 7.13565e-06
RYR3 [NCBI] 7.13565e-06
TTPA [NCBI] 7.13565e-06
MECP2 [NCBI] 7.08479e-06
APOB [NCBI] 7.062e-06
LGMD2I [NCBI] 6.98653e-06
BHD [NCBI] 6.98653e-06
sitosterolemia [NCBI] 6.98653e-06
cerebrotendinous xanthomatosis [NCBI] 6.98653e-06
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 [NCBI] 6.98653e-06
WGN1 [NCBI] 6.98653e-06
tetralogy of fallot [NCBI] 6.98653e-06
kaposi sarcoma [NCBI] 6.98653e-06
asplenia with cardiovascular anomalies [NCBI] 6.98653e-06
JBS [NCBI] 6.98653e-06
myoclonic epilepsy of unverricht and lundborg [NCBI] 6.97616e-06
aHUS [NCBI] 6.97616e-06
CTNS [NCBI] 6.97616e-06
CDLS1 [NCBI] 6.95188e-06
SOD1 [NCBI] 6.85777e-06
LEPR [NCBI] 6.84396e-06
SALL4 [NCBI] 6.70435e-06
DLGAP1 [NCBI] 6.70435e-06
OLIG2 [NCBI] 6.70435e-06
GNAQ [NCBI] 6.70435e-06
SIRT2 [NCBI] 6.70435e-06
XDH [NCBI] 6.66469e-06
CMT1A [NCBI] 6.49845e-06
isoniazid inactivation [NCBI] 6.44963e-06
ABCC1 [NCBI] 6.33285e-06
ACTG1 [NCBI] 6.3113e-06
CSPG5 [NCBI] 6.3113e-06
OLR1 [NCBI] 6.3113e-06
AQP7 [NCBI] 6.3113e-06
PDE4D [NCBI] 6.3113e-06
FH [NCBI] 6.28799e-06
IDE [NCBI] 6.28528e-06
APC [NCBI] 6.24435e-06
VIM [NCBI] 6.17868e-06
RLBP1 [NCBI] 6.13059e-06
vitamin d-dependent rickets, type i [NCBI] 6.11726e-06
lipoid congenital adrenal hyperplasia [NCBI] 6.11726e-06
MCPH1 [NCBI] 6.11726e-06
CFTD [NCBI] 6.11726e-06
JH [NCBI] 6.11726e-06
myasthenic syndrome, congenital, associated with episodic apnea [NCBI] 6.11726e-06
holocarboxylase synthetase deficiency [NCBI] 6.11726e-06
ichthyosis congenita, harlequin fetus type [NCBI] 6.11726e-06
chromosome 5q deletion syndrome [NCBI] 6.11726e-06
DSCR1 [NCBI] 5.95104e-06
OGG1 [NCBI] 5.95104e-06
PRPH [NCBI] 5.95104e-06
LU [NCBI] 5.95104e-06
SCN2A [NCBI] 5.95104e-06
HABP2 [NCBI] 5.95104e-06
PI [NCBI] 5.93693e-06
MPO [NCBI] 5.88768e-06
CPB2 [NCBI] 5.86857e-06
phenylketonuria [NCBI] 5.82218e-06
AVSD [NCBI] 5.78843e-06
ALS1 [NCBI] 5.78843e-06
TNFRSF11B [NCBI] 5.75966e-06
MBP [NCBI] 5.72145e-06
PLP1 [NCBI] 5.68231e-06
KSS [NCBI] 5.67945e-06
SIX5 [NCBI] 5.61917e-06
TBX21 [NCBI] 5.61917e-06
LOR [NCBI] 5.61917e-06
PFC [NCBI] 5.61917e-06
CTNS [NCBI] 5.61917e-06
PLAU [NCBI] 5.61917e-06
EFNB2 [NCBI] 5.61917e-06
HEPH [NCBI] 5.61917e-06
NTRK3 [NCBI] 5.61917e-06
DRD2 [NCBI] 5.54039e-06
PSEN2 [NCBI] 5.54039e-06
BMD [NCBI] 5.54032e-06
IGER [NCBI] 5.54032e-06
TLR4 [NCBI] 5.38817e-06
IAPP [NCBI] 5.37731e-06
ASPS [NCBI] 5.34364e-06
diabetes insipidus, neurohypophyseal type [NCBI] 5.34364e-06
helicobacter pylori infection, susceptibility to [NCBI] 5.34364e-06
PPAC [NCBI] 5.34364e-06
hurler-scheie syndrome [NCBI] 5.34364e-06
GCE [NCBI] 5.34364e-06
GSD [NCBI] 5.34364e-06
VED [NCBI] 5.34364e-06
alexander disease [NCBI] 5.34364e-06
PANK2 [NCBI] 5.31215e-06
MC3R [NCBI] 5.31215e-06
TXNIP [NCBI] 5.31215e-06
THBD [NCBI] 5.31215e-06
ELAC2 [NCBI] 5.31215e-06
BAK1 [NCBI] 5.31215e-06
TLR1 [NCBI] 5.31215e-06
BEST1 [NCBI] 5.31215e-06
CYBA [NCBI] 5.31215e-06
asthma, susceptibility to [NCBI] 5.15087e-06
CRX [NCBI] 5.02704e-06
ATXN7 [NCBI] 5.02704e-06
NR5A2 [NCBI] 5.02704e-06
SCNN1A [NCBI] 5.02704e-06
DNMT3A [NCBI] 5.02704e-06
GCG [NCBI] 5.02704e-06
PEG3 [NCBI] 5.02704e-06
FGB [NCBI] 5.02704e-06
PKD2 [NCBI] 5.00694e-06
HNF4A [NCBI] 5.00694e-06
TFPI [NCBI] 4.9353e-06
RTT [NCBI] 4.92017e-06
BCHE [NCBI] 4.85638e-06
alopecia, androgenetic [NCBI] 4.82451e-06
HLF [NCBI] 4.7614e-06
TCRD [NCBI] 4.7614e-06
GLDC [NCBI] 4.7614e-06
SREBF1 [NCBI] 4.7614e-06
TCF3 [NCBI] 4.7614e-06
VMD [NCBI] 4.71081e-06
DYT3 [NCBI] 4.65367e-06
periodontitis, aggressive, 1 [NCBI] 4.65367e-06
FXTAS [NCBI] 4.65367e-06
diabetes-deafness syndrome, maternally transmitted [NCBI] 4.65367e-06
EVR1 [NCBI] 4.65367e-06
longevity [NCBI] 4.65367e-06
DHRD [NCBI] 4.65367e-06
pituitary dwarfism iii [NCBI] 4.65367e-06
NPM1 [NCBI] 4.59386e-06
CFH [NCBI] 4.59386e-06
lynch syndrome i [NCBI] 4.52862e-06
FGF9 [NCBI] 4.51319e-06
PCDH15 [NCBI] 4.51319e-06
SLC1A1 [NCBI] 4.51319e-06
FUT2 [NCBI] 4.51319e-06
APRT [NCBI] 4.50655e-06
AKR1B1 [NCBI] 4.50655e-06
EV [NCBI] 4.42657e-06
EDMD [NCBI] 4.33072e-06
SLC6A3 [NCBI] 4.31652e-06
tay-sachs disease, ab variant [NCBI] 4.28065e-06
SN [NCBI] 4.28065e-06
HAP1 [NCBI] 4.28065e-06
GALK1 [NCBI] 4.28065e-06
TMOD [NCBI] 4.28065e-06
NNMT [NCBI] 4.28065e-06
NCSTN [NCBI] 4.28065e-06
PGD [NCBI] 4.28065e-06
osteogenesis imperfecta, type i [NCBI] 4.24483e-06
BCR [NCBI] 4.23503e-06
GIST [NCBI] 4.13925e-06
DSPP [NCBI] 4.08314e-06
EPHB2 [NCBI] 4.06229e-06
GJB6 [NCBI] 4.06229e-06
DRD3 [NCBI] 4.06229e-06
properdin deficiency, x-linked [NCBI] 4.0375e-06
factor xii deficiency [NCBI] 4.0375e-06
glycogen storage disease iv [NCBI] 4.0375e-06
MNS [NCBI] 4.0375e-06
FBS [NCBI] 4.0375e-06
bladder cancer [NCBI] 4.0375e-06
DYT1 [NCBI] 3.97234e-06
ornithine transcarbamylase deficiency, hyperammonemia due to [NCBI] 3.87578e-06
DLK1 [NCBI] 3.85683e-06
CYCS [NCBI] 3.85683e-06
GHRHR [NCBI] 3.85683e-06
HLA-DQB1 [NCBI] 3.85683e-06
ASIP [NCBI] 3.85683e-06
JUN [NCBI] 3.85683e-06
FUS [NCBI] 3.85683e-06
MBL2 [NCBI] 3.83918e-06
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 3.80334e-06
DRD4 [NCBI] 3.77892e-06
MC4R [NCBI] 3.77892e-06
VAMP2 [NCBI] 3.66314e-06
AACT [NCBI] 3.66314e-06
TCOF1 [NCBI] 3.66314e-06
RHD [NCBI] 3.66314e-06
GJB3 [NCBI] 3.66314e-06
EEF2 [NCBI] 3.66314e-06
LAMB3 [NCBI] 3.66314e-06
DLD [NCBI] 3.66314e-06
CRIP1 [NCBI] 3.66314e-06
LTC4S [NCBI] 3.66314e-06
SLC5A7 [NCBI] 3.66314e-06
IP [NCBI] 3.65698e-06
TF [NCBI] 3.65366e-06
CHH [NCBI] 3.63555e-06
thyroid carcinoma, papillary [NCBI] 3.63467e-06
SCA6 [NCBI] 3.63467e-06
LRRK2 [NCBI] 3.58738e-06
TNFSF6 [NCBI] 3.52083e-06
TPO [NCBI] 3.50381e-06
ARSA [NCBI] 3.49482e-06
CLN2 [NCBI] 3.48692e-06
HNA [NCBI] 3.48692e-06
pancreatic carcinoma [NCBI] 3.48692e-06
MFN2 [NCBI] 3.48023e-06
IRF1 [NCBI] 3.48023e-06
CDH23 [NCBI] 3.48023e-06
ACOX1 [NCBI] 3.48023e-06
CASP1 [NCBI] 3.48023e-06
FGF7 [NCBI] 3.47468e-06
osteogenesis imperfecta, type iia [NCBI] 3.31682e-06
PIAS1 [NCBI] 3.30725e-06
HK1 [NCBI] 3.30725e-06
HLA-DRB1 [NCBI] 3.30725e-06
MYH9 [NCBI] 3.30725e-06
JAK2 [NCBI] 3.27911e-06
KCNH2 [NCBI] 3.27911e-06
ALK [NCBI] 3.26941e-06
FGF8 [NCBI] 3.22928e-06
lymphoma, non-hodgkin, familial [NCBI] 3.18089e-06
LYZ [NCBI] 3.14343e-06
GALC [NCBI] 3.14343e-06
MAPK7 [NCBI] 3.14343e-06
hypercholesterolemia, autosomal dominant [NCBI] 3.1171e-06
glioma of brain, familial [NCBI] 3.01792e-06
mucopolysaccharidosis type iiib [NCBI] 2.99502e-06
SCA10 [NCBI] 2.99502e-06
DA2A [NCBI] 2.99502e-06
PLOSL [NCBI] 2.99502e-06
MEN2B [NCBI] 2.99502e-06
PPARGC1A [NCBI] 2.98809e-06
LRP8 [NCBI] 2.98809e-06
GSTM1 [NCBI] 2.98809e-06
RDT [NCBI] 2.94742e-06
TCOF [NCBI] 2.94742e-06
DBI [NCBI] 2.93728e-06
BSG [NCBI] 2.90173e-06
SRF [NCBI] 2.87478e-06
AHR [NCBI] 2.85438e-06
SLC17A7 [NCBI] 2.84062e-06
MYCN [NCBI] 2.84062e-06
DYT1 [NCBI] 2.84062e-06
TNNT2 [NCBI] 2.84062e-06
PROP1 [NCBI] 2.84062e-06
FAAH [NCBI] 2.82611e-06
VIP [NCBI] 2.74412e-06
HHT [NCBI] 2.73718e-06
TCRB [NCBI] 2.70049e-06
FABP2 [NCBI] 2.70049e-06
HLA-DQA1 [NCBI] 2.70049e-06
ASS [NCBI] 2.67437e-06
DMD [NCBI] 2.64291e-06
MS [NCBI] 2.61684e-06
NCOA2 [NCBI] 2.5672e-06
PBP [NCBI] 2.5672e-06
ADK [NCBI] 2.5672e-06
DHH [NCBI] 2.5672e-06
NOS2A [NCBI] 2.5672e-06
MB [NCBI] 2.56455e-06
hyperoxaluria, primary, type i [NCBI] 2.55591e-06
histidinemia [NCBI] 2.55591e-06
LCT [NCBI] 2.53091e-06
STAR [NCBI] 2.46675e-06
PMP22 [NCBI] 2.46321e-06
UCP3 [NCBI] 2.4615e-06
COL4A5 [NCBI] 2.44031e-06
RBP4 [NCBI] 2.44031e-06
MSH6 [NCBI] 2.44031e-06
AQP3 [NCBI] 2.44031e-06
STAT4 [NCBI] 2.44031e-06
E2F1 [NCBI] 2.44031e-06
PRODH [NCBI] 2.44031e-06
GRP [NCBI] 2.4277e-06
EPOR [NCBI] 2.4277e-06
PYY [NCBI] 2.41865e-06
PXE [NCBI] 2.36494e-06
PEDF [NCBI] 2.35713e-06
CAT [NCBI] 2.33718e-06
GCH1 [NCBI] 2.31942e-06
CETP [NCBI] 2.31942e-06
SCA7 [NCBI] 2.22723e-06
WS1 [NCBI] 2.22723e-06
MTND6 [NCBI] 2.20417e-06
TERC [NCBI] 2.20417e-06
MTND5 [NCBI] 2.20417e-06
deafness, conductive, with stapes fixation [NCBI] 2.16458e-06
PLG [NCBI] 2.13166e-06
GJB2 [NCBI] 2.115e-06
SLS [NCBI] 2.11309e-06
CLCN1 [NCBI] 2.09422e-06
CYBB [NCBI] 2.09422e-06
CFI [NCBI] 2.09422e-06
IL5 [NCBI] 2.09422e-06
SOX10 [NCBI] 2.09422e-06
DNAJC5 [NCBI] 2.09422e-06
GRPR [NCBI] 2.09422e-06
ARPKD [NCBI] 1.99666e-06
NPY [NCBI] 1.99469e-06
GLB1 [NCBI] 1.98927e-06
GSN [NCBI] 1.98927e-06
MTTK [NCBI] 1.98927e-06
PEPD [NCBI] 1.98927e-06
GPI [NCBI] 1.94189e-06
CHM [NCBI] 1.92081e-06
GHRL [NCBI] 1.88905e-06
aspartylglucosaminuria [NCBI] 1.88905e-06
MSD [NCBI] 1.81666e-06
MLC [NCBI] 1.81666e-06
EKV [NCBI] 1.81666e-06
bartter syndrome, type 3 [NCBI] 1.81666e-06
sudden infant death syndrome [NCBI] 1.81666e-06
DRD [NCBI] 1.81666e-06
TGD [NCBI] 1.81666e-06
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency [NCBI] 1.81666e-06
NGB [NCBI] 1.7933e-06
NR6A1 [NCBI] 1.7933e-06
coproporphyria [NCBI] 1.7933e-06
NTRK2 [NCBI] 1.7933e-06
GATA1 [NCBI] 1.7933e-06
SPS [NCBI] 1.78949e-06
RCC1 [NCBI] 1.7815e-06
EPO [NCBI] 1.76969e-06
DNMT1 [NCBI] 1.71878e-06
krabbe disease [NCBI] 1.71045e-06
MTCO1 [NCBI] 1.70178e-06
BGN [NCBI] 1.70178e-06
dystrophia myotonica 1 [NCBI] 1.68662e-06
GH1 [NCBI] 1.68488e-06
hemophilia a [NCBI] 1.65526e-06
LMNA [NCBI] 1.63384e-06
HDGF [NCBI] 1.61428e-06
RS1 [NCBI] 1.61428e-06
ADRB2 [NCBI] 1.61428e-06
hurler syndrome [NCBI] 1.58118e-06
apc gene [NCBI] 1.56136e-06
bullous erythroderma ichthyosiformis congenita of brocq [NCBI] 1.55754e-06
SLC1A2 [NCBI] 1.53059e-06
HNMT [NCBI] 1.53059e-06
PPT1 [NCBI] 1.53059e-06
C4B [NCBI] 1.53059e-06
transcobalamin ii deficiency [NCBI] 1.53059e-06
biotinidase deficiency [NCBI] 1.50838e-06
CMM2 [NCBI] 1.50838e-06
glycogen storage disease v [NCBI] 1.50838e-06
glycogen storage disease ib [NCBI] 1.50838e-06
ABCG2 [NCBI] 1.5063e-06
ALD [NCBI] 1.48204e-06
ATP7B [NCBI] 1.45053e-06
fucosidosis [NCBI] 1.45053e-06
APP [NCBI] 1.43528e-06
MAP2 [NCBI] 1.41491e-06
ABP1 [NCBI] 1.37894e-06
GAA [NCBI] 1.37392e-06
protoporphyria, erythropoietic [NCBI] 1.37392e-06
PCNA [NCBI] 1.35817e-06
WT1 [NCBI] 1.32015e-06
TCRG [NCBI] 1.30062e-06
MMP3 [NCBI] 1.30062e-06
ACADM [NCBI] 1.29053e-06
PLTP [NCBI] 1.29053e-06
TP53 [NCBI] 1.27569e-06
SERPINA6 [NCBI] 1.24122e-06
thiourea tasting [NCBI] 1.23644e-06
gaucher disease, type iii [NCBI] 1.23644e-06
ODDD [NCBI] 1.23644e-06
SEDC [NCBI] 1.23644e-06
SOCS1 [NCBI] 1.23045e-06
BRAF [NCBI] 1.23045e-06
ADIPOQ [NCBI] 1.23045e-06
maple syrup urine disease [NCBI] 1.22455e-06
CCM [NCBI] 1.22455e-06
HHF2 [NCBI] 1.22455e-06
PC [NCBI] 1.22255e-06
MCP [NCBI] 1.20408e-06
FGFR3 [NCBI] 1.16334e-06
ENG [NCBI] 1.1633e-06
FBN1 [NCBI] 1.14206e-06
IL6 [NCBI] 1.11966e-06
APS1 [NCBI] 1.11314e-06
KAL1 [NCBI] 1.09902e-06
IL2RA [NCBI] 1.09902e-06
PDCD8 [NCBI] 1.09855e-06
fabry disease [NCBI] 1.08401e-06
down syndrome [NCBI] 1.07017e-06
LQT1 [NCBI] 1.06384e-06
PTEN [NCBI] 1.03734e-06
AS [NCBI] 1.02782e-06
VASP [NCBI] 1.01039e-06
DYX1 [NCBI] 9.97925e-07
dyschromatosis symmetrica hereditaria 1 [NCBI] 9.97925e-07
RP [NCBI] 9.92195e-07
ABCA1 [NCBI] 9.78596e-07
factor x deficiency [NCBI] 9.78596e-07
DMPK [NCBI] 9.78596e-07
ERBB2 [NCBI] 9.78596e-07
TCF7L2 [NCBI] 9.78596e-07
IFNG [NCBI] 9.78596e-07
TNFRSF6 [NCBI] 9.78596e-07
TSC1 [NCBI] 9.78596e-07
PAM [NCBI] 9.56579e-07
SOD2 [NCBI] 9.3711e-07
ABCB1 [NCBI] 9.3101e-07
galactosemia [NCBI] 9.24323e-07
LNS [NCBI] 9.24323e-07
BRRS [NCBI] 9.24323e-07
HBG2 [NCBI] 9.22236e-07
GIP [NCBI] 9.12781e-07
CDK5 [NCBI] 9.1154e-07
HMBS [NCBI] 9.05059e-07
GC [NCBI] 8.79367e-07
HCRT [NCBI] 8.68305e-07
FGF23 [NCBI] 8.68305e-07
STAT1 [NCBI] 8.53938e-07
PKD1 [NCBI] 8.23423e-07
RP2 [NCBI] 8.16707e-07
OPTB1 [NCBI] 7.90265e-07
FHM1 [NCBI] 7.90265e-07
NPS [NCBI] 7.87364e-07
MAP1B [NCBI] 7.67354e-07
PVR [NCBI] 7.67354e-07
CFB [NCBI] 7.2016e-07
MTND1 [NCBI] 7.2016e-07
CSF3 [NCBI] 7.2016e-07
SCN5A [NCBI] 7.2016e-07
ADCYAP1 [NCBI] 6.96612e-07
RHO [NCBI] 6.83605e-07
DFSP [NCBI] 6.3762e-07
LHCGR [NCBI] 6.31934e-07
IGFALS [NCBI] 6.20234e-07
usher syndrome, type i [NCBI] 6.11173e-07
SPDA1 [NCBI] 6.11173e-07
RNASE3 [NCBI] 6.0849e-07
DDC [NCBI] 5.92638e-07
MSH2 [NCBI] 5.90756e-07
KIT [NCBI] 5.90756e-07
CRH [NCBI] 5.57916e-07
GJA1 [NCBI] 5.56199e-07
PGM1 [NCBI] 5.51441e-07
NFKB1 [NCBI] 5.51441e-07
A2M [NCBI] 5.51441e-07
NIDDM [NCBI] 5.51332e-07
hemophagocytic lymphohistiocytosis, familial, 1 [NCBI] 5.43116e-07
BCNS [NCBI] 5.28236e-07
FGFR1 [NCBI] 5.27658e-07
RET [NCBI] 5.19878e-07
GNRHR [NCBI] 5.13927e-07
WBS [NCBI] 5.13403e-07
PNPLA6 [NCBI] 4.96472e-07
SLPI [NCBI] 4.96472e-07
PCD [NCBI] 4.61709e-07
apert syndrome [NCBI] 4.58607e-07
STGD1 [NCBI] 4.58607e-07
RP1 [NCBI] 4.58607e-07
porphyria variegata [NCBI] 4.52039e-07
TNC [NCBI] 4.51609e-07
MAG [NCBI] 4.46284e-07
spermatogenic failure, nonobstructive, y-linked [NCBI] 4.33825e-07
LDLR [NCBI] 4.24892e-07
CDH1 [NCBI] 4.1159e-07
MMP9 [NCBI] 4.1159e-07
CDKN2A [NCBI] 4.06591e-07
MITF [NCBI] 4.06591e-07
ACE [NCBI] 3.84446e-07
MTND4 [NCBI] 3.80696e-07
KLF1 [NCBI] 3.80696e-07
FMR1 [NCBI] 3.8036e-07
INS [NCBI] 3.76688e-07
CCND1 [NCBI] 3.69019e-07
NF2 [NCBI] 3.51325e-07
ITGB3 [NCBI] 3.51325e-07
MAPT [NCBI] 3.50779e-07
GAPDH [NCBI] 3.46008e-07
porphyria, acute intermittent [NCBI] 3.3656e-07
XPA [NCBI] 3.3656e-07
LSA [NCBI] 3.30737e-07
MMP2 [NCBI] 3.23431e-07
LCN2 [NCBI] 3.23431e-07
CEACAM5 [NCBI] 3.14149e-07
UCP2 [NCBI] 2.98318e-07
GJB1 [NCBI] 2.98318e-07
IRS1 [NCBI] 2.96966e-07
velocardiofacial syndrome [NCBI] 2.8545e-07
PPIA [NCBI] 2.81603e-07
SPARC [NCBI] 2.7189e-07
ELN [NCBI] 2.7189e-07
UCN [NCBI] 2.65285e-07
CYP1A1 [NCBI] 2.54664e-07
BMP4 [NCBI] 2.4937e-07
ESR1 [NCBI] 2.4937e-07
SOCS3 [NCBI] 2.48159e-07
NMU [NCBI] 2.48159e-07
LIPC [NCBI] 2.48159e-07
TGFB1 [NCBI] 2.48159e-07
NOTCH1 [NCBI] 2.48159e-07
CD36 [NCBI] 2.48159e-07
PPARG [NCBI] 2.33866e-07
AGER [NCBI] 2.33287e-07
CNTF [NCBI] 2.33231e-07
LGMD2C [NCBI] 2.25917e-07
FPLD2 [NCBI] 2.25917e-07
GCCR [NCBI] 2.25734e-07
LPL [NCBI] 2.22817e-07
COL1A1 [NCBI] 2.18778e-07
NR5A1 [NCBI] 2.04577e-07
PLAUR [NCBI] 1.89881e-07
VHL [NCBI] 1.88814e-07
TFF3 [NCBI] 1.84653e-07
NGFR [NCBI] 1.78333e-07
RSTS [NCBI] 1.75886e-07
BLM [NCBI] 1.74566e-07
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency [NCBI] 1.74566e-07
LS [NCBI] 1.74566e-07
GAL [NCBI] 1.69109e-07
SLE [NCBI] 1.67046e-07
PAX3 [NCBI] 1.65926e-07
PTHLH [NCBI] 1.64736e-07
MAOA [NCBI] 1.6274e-07
PCOS1 [NCBI] 1.55464e-07
IFNA1 [NCBI] 1.49846e-07
SCZD [NCBI] 1.4476e-07
FGF2 [NCBI] 1.42482e-07
TSC2 [NCBI] 1.31933e-07
TS [NCBI] 1.31552e-07
NR0B2 [NCBI] 1.16605e-07
LOX [NCBI] 1.16605e-07
VCP [NCBI] 1.16605e-07
SRC [NCBI] 1.13971e-07
MTS [NCBI] 1.136e-07
SMEI [NCBI] 1.136e-07
hypophosphatemic rickets, x-linked dominant [NCBI] 1.136e-07
CJD [NCBI] 1.07359e-07
MYOC [NCBI] 1.02977e-07
PIGR [NCBI] 1.02977e-07
MVP [NCBI] 1.02349e-07
LEP [NCBI] 1.01504e-07
FGA [NCBI] 8.91364e-08
AR [NCBI] 8.89587e-08
GUSB [NCBI] 8.24859e-08
costello syndrome [NCBI] 7.96156e-08
PARK2 [NCBI] 7.96156e-08
TG [NCBI] 7.81551e-08
XIST [NCBI] 7.69413e-08
MLH1 [NCBI] 7.69413e-08
PARK2 [NCBI] 7.69413e-08
FTD [NCBI] 7.29734e-08
hypertension, essential [NCBI] 7.11565e-08
PARP1 [NCBI] 6.57371e-08
growth hormone insensitivity syndrome [NCBI] 6.41686e-08
SHH [NCBI] 6.2299e-08
MFS [NCBI] 5.54227e-08
CMH [NCBI] 4.86033e-08
POMC [NCBI] 4.61003e-08
NR1I2 [NCBI] 3.78063e-08
CML [NCBI] 3.55611e-08
SPG4 [NCBI] 3.55611e-08
HCH [NCBI] 3.55611e-08
PTGS2 [NCBI] 3.36983e-08
DMD [NCBI] 3.10386e-08
MTR [NCBI] 3.03417e-08
TRPV1 [NCBI] 3.03417e-08
ARNT [NCBI] 3.03417e-08
G6PD [NCBI] 2.99475e-08
PDS [NCBI] 2.82683e-08
PNMT [NCBI] 2.01437e-08
IBD1 [NCBI] 1.87667e-08
PSACH [NCBI] 1.87667e-08
OXT [NCBI] 1.77067e-08
CPE [NCBI] 1.69606e-08
OPRM1 [NCBI] 1.25921e-08
HIGM1 [NCBI] 9.37874e-09
SJS1 [NCBI] 9.37874e-09
XLP1 [NCBI] 9.37874e-09
CADASIL [NCBI] 9.37874e-09
CLL [NCBI] 9.37874e-09
sandhoff disease [NCBI] 9.37874e-09
FGF1 [NCBI] 8.84986e-09
homocystinuria [NCBI] 8.84986e-09
ADA [NCBI] 8.57406e-09
ATS [NCBI] 6.63045e-09
IHH [NCBI] 6.59528e-09
MPZ [NCBI] 5.74678e-09
antithrombin iii deficiency [NCBI] 5.74678e-09
VHL [NCBI] 5.64269e-09
CVID [NCBI] 2.40931e-09
COL2A1 [NCBI] 1.51247e-09
mucopolysaccharidosis type ii [NCBI] 4.09451e-10
ichthyosis, x-linked [NCBI] 4.09451e-10
SCA2 [NCBI] 9.44732e-11
malaria, susceptibility to [NCBI] 4.72131e-11
OPA1 [NCBI] 4.72131e-11
CLN3 [NCBI] 4.72131e-11
GHR [NCBI] 6.26415e-12
HLA-A [NCBI] 2.08657e-12
BTK [NCBI] 2.08657e-12
GBA [NCBI] 2.08657e-12




Database Center for Life Science